Zepbound Cost Without Insurance: 2026 Pricing Guide

Zepbound Without Insurance: The Key Numbers

Zepbound (tirzepatide) is Eli Lilly's FDA-approved weight management medication. Without insurance, the list price for Zepbound single-dose pens is approximately $1,086 per month for all doses. However, Eli Lilly launched a self-pay vial program through LillyDirect in late 2025 that dramatically changed the economics for uninsured patients:

• Zepbound 2.5 mg vial (LillyDirect): $299/month
• Zepbound 5 mg vial (LillyDirect): $399/month
• Zepbound 7.5 mg–15 mg vials (LillyDirect): $449/month

These vial prices represent a 60–70% reduction from the pen list price and make Zepbound the most affordable branded GLP-1 medication available to cash-paying patients in 2026.

Zepbound Pricing: Every Option Explained

Option 1: LillyDirect Self-Pay Vials (Lowest Cash Price)

The cheapest way to get Zepbound without insurance is through LillyDirect, Eli Lilly's direct-to-patient pharmacy platform. Patients with a valid prescription can order Zepbound single-dose vials at these prices:

Important note on vials vs. pens: Vials require self-injection with a separate insulin syringe, which is slightly more complex than the pre-filled auto-injector pen. However, the medication is identical — same tirzepatide active ingredient, same dosing, same efficacy. Many patients find the technique straightforward after the first injection.

To order through LillyDirect, visit lillydirect.lilly.com. You will need a valid Zepbound prescription, which can be obtained through your doctor or a telehealth provider.

Option 2: Prescription Discount Services ($499–$600/month for Pens)

If you prefer the pre-filled pen format, prescription discount services like RxGo, GoodRx, and SingleCare can reduce the pen price to approximately $499–$600/month at retail pharmacies. This is still significantly less than the $1,086 list price.

Compare Zepbound pen prices at pharmacies near you →

Option 3: Lilly Savings Card (With Commercial Insurance)

If you have commercial insurance that does not cover Zepbound, the Lilly Savings Card can reduce your cost:

• Zepbound pens: As low as $499/month
• Zepbound KwikPen (multi-dose): $299–$449/month depending on dose

The savings card requires commercial insurance enrollment and cannot be used with Medicare, Medicaid, or other government programs. Enroll at zepbound.lilly.com/coverage-savings.

Option 4: Lilly Cares Foundation (Low-Income Patients)

Patients without insurance who meet income eligibility requirements may qualify for free Zepbound through the Lilly Cares Foundation. Eligibility is generally based on household income below 400% of the federal poverty level. Applications are submitted through your prescribing physician.

Does Insurance Cover Zepbound?

Insurance coverage for Zepbound is less consistent than for Mounjaro because obesity treatment has historically received less insurance support than diabetes treatment. Here is the current landscape:

Commercial insurance: Approximately 40% of commercial plans cover Zepbound for chronic weight management as of 2026. Coverage is growing as the clinical evidence base strengthens and employers recognize the long-term cost savings of treating obesity. Prior authorization is required by virtually all plans that do cover it.

Medicare: Medicare does not currently cover GLP-1 medications prescribed solely for weight loss. The Treat and Reduce Obesity Act (TROA) has been introduced in Congress multiple times but has not yet passed. If you have Medicare and a qualifying comorbidity (type 2 diabetes, cardiovascular disease), coverage may apply through a different medication or indication.

Medicaid: Coverage varies significantly by state. As of 2026, fewer than 20 states cover GLP-1 medications for obesity under Medicaid. Contact your state Medicaid office for current formulary information.

Prior Authorization for Zepbound: What Your Doctor Needs

If your insurance does cover Zepbound, prior authorization is almost always required. Your doctor will typically need to document:

• BMI ≥ 30 kg/m² (or ≥ 27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea)
• Evidence of a structured weight management program attempt (diet and exercise)
• No contraindications (personal or family history of medullary thyroid carcinoma or MEN2 syndrome)

The PA process takes 5–10 business days. If denied, you can appeal with a letter of medical necessity. Many appeals succeed, particularly when your doctor documents the clinical necessity clearly.

Zepbound vs. Compounded Tirzepatide: Is Compounding Still Available?

Compounded tirzepatide was widely available in 2024–2025 when Zepbound was on the FDA drug shortage list. Compounded versions cost $200–$400/month — significantly less than the brand-name product. However, the situation changed in early 2026:

The FDA removed tirzepatide from its drug shortage list, which means 503B outsourcing facilities are no longer permitted to compound tirzepatide for general distribution. Some 503A compounding pharmacies may still compound tirzepatide for individual patients with documented medical need, but this pathway is narrowing. Patients currently on compounded tirzepatide should discuss transitioning to brand-name Zepbound with their prescribing provider.

Given that LillyDirect vials now start at $299/month, the price gap between compounded and brand-name tirzepatide has narrowed considerably, making the transition more financially feasible.

Zepbound vs. Wegovy: Which Is Cheaper Without Insurance?

Both Zepbound and Wegovy are FDA-approved for chronic weight management, but they use different active ingredients (tirzepatide vs. semaglutide) and have different pricing structures:

For uninsured patients, Zepbound is significantly cheaper than Wegovy due to the LillyDirect vial program. For insured patients with coverage, both medications can be obtained for $25/month or less with manufacturer savings cards.

See our full Wegovy vs. Mounjaro comparison → for a detailed efficacy and side effect comparison.

How to Get Zepbound for the Lowest Price: Step-by-Step

1. Check your insurance first. Log into your insurance portal or call member services and ask whether Zepbound is on your formulary. If it is, use the Lilly Savings Card to pay as little as $25/month.

2. If not covered, choose vials over pens. Order through LillyDirect at $299–$449/month — the lowest available cash price for brand-name tirzepatide.

3. If you prefer pens, use a discount service. RxGo, GoodRx, and SingleCare can reduce pen prices to $499–$600/month at retail pharmacies.

4. Check income eligibility for free medication. If your household income is below 400% of the federal poverty level, apply to the Lilly Cares Foundation for free Zepbound.

5. Consider telehealth for your prescription. Telehealth platforms like Hims & Hers, Ro, and Noom Med can prescribe Zepbound and often bundle the prescription with LillyDirect ordering, simplifying the process for patients without a primary care provider.

Frequently Asked Questions

What is the cheapest way to get Zepbound without insurance? LillyDirect self-pay vials at $299/month for the 2.5 mg starting dose. This is the lowest available cash price for brand-name tirzepatide.

Can I use GoodRx for Zepbound? Yes. GoodRx and other discount services work for Zepbound pens at retail pharmacies, typically reducing the price to $499–$600/month. However, LillyDirect vials at $299–$449/month are usually cheaper than GoodRx pen prices.

Is Zepbound the same as Mounjaro? Both contain tirzepatide, but they are different FDA-approved products. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management. The dosing and injection schedule are the same, but they have different FDA labeling, different insurance coverage profiles, and different savings programs.

Does Zepbound work better than Ozempic? Clinical trials show that tirzepatide (Zepbound) produces greater average weight loss (~20–22% of body weight) compared to semaglutide (Ozempic/Wegovy, ~15% of body weight). However, individual results vary, and both medications are highly effective. See our Ozempic vs. Wegovy comparison for more detail.

How long do I need to take Zepbound? Zepbound is a chronic medication — weight typically returns when the medication is stopped. Most clinical guidelines recommend continuing treatment indefinitely for patients who respond well and tolerate the medication.